VRUCYVSBVGTFGX-UHFFFAOYSA-N
|
|
VRUCYVSBVGTFGX-UHFFFAOYSA-N Eigenschaften
- Siedepunkt:
- 479.3±55.0 °C(Predicted)
- Dichte
- 1.42±0.1 g/cm3(Predicted)
- pka
- -1.59±0.20(Predicted)
Sicherheit
VRUCYVSBVGTFGX-UHFFFAOYSA-N Chemische Eigenschaften,Einsatz,Produktion Methoden
VRUCYVSBVGTFGX-UHFFFAOYSA-N Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
VRUCYVSBVGTFGX-UHFFFAOYSA-N Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 13)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Coresyn Pharmatech Co., Ltd. | +86-571-86626709 +86-18157142896 |
cbc@coresyn.com | China | 9984 | 58 |
Xuzhou B&C Chemical Co.,Ltd | +86-400-0516-021 |
info@bcpharma.com | China | 2738 | 58 |
Nanjing Bicbiotechnology Co., Ltd | +86-2552131256 +86-18251840740 |
sales@bicbiotech.com | China | 5994 | 58 |
Allfluoro pharmaceutical co. ltd. | 021-26137118 +8615821363818 |
sales@allfluoro.com | China | 5790 | 58 |
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. | 0531-58897130 15508676053 |
drug_impurity@sdcclh.com | China | 2017 | 58 |
Beijing xinyanhui pharmaceutical research and development co., LTD | 13969155946 |
1461866103@qq.com | China | 16111 | 58 |
QUALITY CONTROL SOLUTIONS LTD. | 0755-66853366; 13670046396 |
ORDERS@QCSRM.COM | China | 24342 | 58 |
Changzhou Bojia Biomedical Technology Co., Ltd. | 2122619822 |
czbjpharma@126.com | China | 18478 | 58 |
Xuzhou B&C Chemical Co.,Ltd | 400-0516-021 19121335088 |
info@bcpharma.com | China | 2750 | 58 |
Nanjing Huanuo Biomedical Technology Co., Ltd | 18913906212 |
2885426135@qq.com | China | 7160 | 58 |
- VRUCYVSBVGTFGX-UHFFFAOYSA-N
- METHYL 2-(2-CHLORO-8-FLUORO-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-1,2,3,4-TETRAHYDROQUINAZOLIN-4-Y
- methyl 2-(2-chloro-8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroquinazolin-4-yl)acetate
- Methyl 2-(2-chloro-8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4H-quinazolin-4-yl)acetate
- LeterMovir-018
- 4-Quinazolineacetic acid, 2-chloro-8-fluoro-3,4-dihydro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester
- methyl 2-chloro-8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-3,4-dihydroquinazoline-4-carboxylate
- LeterMovir Impurity 21
- Letermovir Impurity 37
- 917389-18-5